Hassanain M, Tchervenkov J, Cantarovich M, Metrakos P, Paraskevas S, Keith D, Baran D, Fernandez M, Mangel R, Chaudhury P
Department of Surgery, McGill University, Montreal, Quebec, Canada.
Transplant Proc. 2009 Jan-Feb;41(1):133-4. doi: 10.1016/j.transproceed.2008.10.044.
The use of expanded criteria donors (ECDs) is still limited because of inferior graft survival compared to standard criteria donors (SCDs). We assessed the impact of immediate graft function (IGF) on renal graft survival among recipients of SCD and ECD grafts to determine whether these kidneys performed equally well under "ideal" conditions favoring IGF.
We included all cadaveric renal transplants performed from 1990 to 2002 (n = 335). Delayed graft function (DGF) was defined as the need for dialysis in the first 7 days posttransplant. Slow graft function (SGF) and IGF were defined as a serum creatinine fall by <20% versus >20% in the first 24 hours posttransplant, respectively. Non-death censored actual graft survivals are reported herein.
Seventy-two of the 335 subjects (21.5%) received organs from ECDs and displayed IGF in 54.7%, SGF 16.2%, and DGF 29.1%. Among SCDs, the SGF and DGF rates were 15.3% and 23.4%, respectively. In ECD, the SGF and DGF rates were 19.4% and 50% (P < .02). Actual graft survivals at 1 and 5 years was 86.3% and 70.4%, respectively. Patients with IGF had higher actual graft survival at 5 years compared to SGF and DGF (83.5% vs 74.1% vs 45.4%). DGF had an equally bad impact on actual 5-year graft survival in SCDs and ECDs (42.6% vs 50%).
DGF has a strong detrimental impact on 5-year graft survival. There is a higher rate of DGF in ECD versus SCD kidneys. The detrimental impact on 5-year actual graft survival is equal in SCD and ECD kidneys. Minimizing DGF should be our goal.
与标准标准供体(SCD)相比,扩大标准供体(ECD)的使用仍受到限制,因为其移植物存活率较低。我们评估了即刻移植物功能(IGF)对SCD和ECD移植物受者肾移植存活的影响,以确定这些肾脏在有利于IGF的“理想”条件下是否表现同样良好。
我们纳入了1990年至2002年进行的所有尸体肾移植(n = 335)。延迟移植物功能(DGF)定义为移植后前7天需要透析。缓慢移植物功能(SGF)和IGF分别定义为移植后前24小时血清肌酐下降<20%与>20%。本文报告了非死亡删失的实际移植物存活率。
335名受试者中有72名(21.5%)接受了ECD的器官,其中54.7%表现为IGF,16.2%为SGF,29.1%为DGF。在SCD中,SGF和DGF发生率分别为15.3%和23.4%。在ECD中,SGF和DGF发生率分别为19.4%和50%(P <.02)。1年和5年时的实际移植物存活率分别为86.3%和70.4%。与SGF和DGF相比,IGF患者5年时的实际移植物存活率更高(83.5%对74.1%对45.4%)。DGF对SCD和ECD的实际5年移植物存活率有同样不利的影响(42.6%对50%)。
DGF对5年移植物存活率有强烈的不利影响。ECD肾脏的DGF发生率高于SCD肾脏。对5年实际移植物存活率的不利影响在SCD和ECD肾脏中是相同的。将DGF降至最低应是我们的目标。